Payment Models. Model 1: USD [***] due and payable thirty (30) days after the signing of this Agreement; plus • USD [***] due and payable after the date of FDA notification if the initial NDA results in a final FDA approval of the Product for the indication HTG upon the later of (i) thirty (30) days after such notification, and (ii) the transfer of the Registration for the Product to RELIANT; or • USD [***] due and payable thirty (30) days after the date of FDA notification if the initial NDA results in an Approvable Letter (unless RELIANT shall not have provided a notice to PRONOVA under Section 3.3(a)), plus USD [***] due and payable upon the later of (i) thirty (30) days after the date of FDA notification of final FDA approval of the Product for the indication HTG, and (ii) the transfer of the Registration for the Product to RELIANT. Model 2: USD [***] due and payable thirty (30) days after signing of this Agreement; plus • USD [***] due and payable after the date of FDA notification if the initial NDA results in a final FDA approval of the Product for the indication HTG upon the later of (i) thirty (30) days after such notification, and (ii) the transfer of the Registration for the Product to RELIANT; or • USD [***] due and payable thirty (30) days after the date of FDA notification if the initial NDA results in an Approvable Letter from FDA (unless RELIANT shall not have provided a notice to PRONOVA under Section 3.3(a)), plus USD [***] due and payable upon the later of (i) thirty (30) days after the date of FDA notification of final FDA approval of the Product for the indication HTG, and (ii) the transfer of the Registration for the Product to RELIANT. RELIANT’s obligation to make any of the foregoing “final FDA approval” payments shall be conditioned upon RELIANT’s having received access to validated API to create finished encapsulated Product for sale in the Territory. [***]: Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. Schedule 5.2
Payment Models. The Customer will be billed either after the respective Billing Period based on its actual usage of IDE Services (post-paid Fees), or the Customer can purchase a Subscription to individual IDE Services, in which case the Fees must be paid up front (prepaid Fees).
Payment Models. The payment models available to GPs providing services to the LHNs are expanded with an additional onsite sessional (or hourly rate) payment. The current two payments methods (off-site sessional and FFS) will remain available with significant enhancements. The LHNs will, in consultation with the GP/GP Clinic, determine the payment model to be offered for contracted services based on the LHN’s service delivery requirements.
Payment Models. The Schedule of Fees payable to GPs, as detailed in a GP Agreement, is known as 'SAMSOF' (South Australian Medical Schedule of Fees). A GP Agreement and the SAMSOF provides the application of the payment model in detail and represents the legally enforceable arrangements agreed at the local level between the relevant RLHN and GP/GP Clinic. Each RLHN will offer a GP/GP clinic, via a GP Agreement, a combination of the following payment models:
Payment Models
